Sorrento Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sorrento Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2023.
  • Sorrento Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2023 was $53.4M, a 38% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $53.4M -$32.7M -38% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $85.4M +$504K +0.59% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $86.5M +$1.29M +1.52% Dec 31, 2022 10-Q 2023-08-14
Q3 2022 $85.3M +$8.59M +11.2% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $86.1M +$48.3M +128% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $84.9M +$45.9M +118% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $85.2M +$43.1M +103% Dec 31, 2021 10-K 2023-03-16
Q3 2021 $76.7M +$31.8M +71% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $37.8M -$7.3M -16.2% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $39M -$7.32M -15.8% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $42.1M -$4.33M -9.34% Dec 31, 2020 10-K 2022-03-11
Q3 2020 $44.8M -$2.97M -6.21% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $45.1M -$1.62M -3.46% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $46.3M +$3.04M +7.02% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $46.4M +$1.48M +3.31% Dec 31, 2019 10-K 2021-02-19
Q3 2019 $47.8M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $46.7M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $43.3M Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $44.9M Jan 1, 2019 10-K 2020-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.